Urology
Volume 61, Issue 1 , Pages 2-4 , January 2003

Informed consent for prostate-specific antigen screening

  • Simon Wilkinson

      Affiliations

    • Weiss Memorial Hospital, University of Chicago Priztker School of Medicine, Chicago, Illinois, USA
    • Corresponding Author InformationReprint requests: Simon Wilkinson, M.B., B.S., M.R.C.S., Midwest Prostate and Urology Health Center, Weiss Memorial Hospital, 4646 North Marine Drive, Chicago, IL 60640, USA
    • ,
  • Gerald Chodak

      Affiliations

    • Weiss Memorial Hospital, University of Chicago Priztker School of Medicine, Chicago, Illinois, USA

Received 28 June 2002 ,Accepted 16 August 2002.

References 

  1. Jemal A, Thomas A, Murray T, et al.  Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23–47
  2. Smith RA, von Eschenbach AC, Wender R, et al: American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin 51: 38–75; quiz 77–80, 2001
  3. Minnesota Department of Health: Cancer data from the Minnesota Cancer Surveillance System. Available at: http://www.cancer.umn.edu. Accessed June 20, 2002
  4. Greenlee RT, Hill-Harmon MB, Thun M. Cancer statistics. CA Cancer J Clin. 2001;51:15–36
  5. Albertsen PC, Fryback DG, Storer BE, et al.  Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995;274:626–631
  6. Oliver SE, Gunnell D, Donovan JL. Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet. 2000;355:1788–1789
  7. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet. 2000;355:129–134
  8. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94:167–173
  9. Schilling FH, Spix C, Berthold F, et al.  Neuroblastoma screening at one year of age. N Engl J Med. 2002;346:1047–1053
  10. Woods WG, Gao RN, Shuster JJ, et al.  Screening infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041–1046
  11. Yoneda A, Oue T, Imura K, et al.  Observation of untreated patients with neuroblastoma detected by mass screening (a “wait and see” pilot study). Med Pediatr Oncol. 2001;36:160–162
  12. Roter DL, Hall JA, Merisca R, et al.  Effectiveness of interventions to improve patient compliance (a meta-analysis). Med Care. 1998;36:1138–1161
  13. Morris J, Royle GT. Choice of surgery for early breast cancer (pre- and postoperative levels of clinical anxiety and depression in patients and their husbands). Br J Surg. 1987;74:1017–1019
  14. Bertakis KD. The communication of information from physician to patient (a method for increasing patient retention and satisfaction). J Fam Pract. 1977;5:217–222
  15. Kaplan SH, Greenfield S, Ware JE. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110–S127
  16. Greenfield S, Kaplan SH, Ware JE, et al.  Patients’ participation in medical care (effects on blood sugar control and quality of life in diabetes). J Gen Intern Med. 1988;3:448–457
  17. Schroder FH, Wildhagen MF. Screening for prostate cancer (evidence and perspectives). BJU Int. 2001;88:811–817
  18. Cockburn J, Redman S, Mill D, et al.  Public understanding of medical screening. J Med Screen. 1995;2:224–227

PII: S0090-4295(02)02010-1

Urology
Volume 61, Issue 1 , Pages 2-4 , January 2003

Article Tools